Want to see TSE:ARCH full AI Analyst Report?
Arch Biopartners (ARCH) Income Statement
Arch Biopartners Income Statement
Last quarter (Q3 2026), Arch Biopartners's total revenue was $0.00. In Q3, Arch Biopartners's net income was $-475.11K. See Arch Biopartners’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 2.12M | $ 1.98M | $ 964.68K | $ 3.89M | |
| $ 0.00 | $ -1.66M | $ -129.00K | $ -503.00K | $ -150.00K | |
| $ 1.52M | $ 2.29M | $ 3.35M | $ 1.08M | $ 1.17M | |
| Depreciation and Amortization | $ 0.00 | $ 3.46M | $ 2.90M | $ 997.10K | $ 819.38K |
| $ -1.29M | $ -75.40K | $ -335.99K | $ -101.90K | $ -76.62K | |
| $ -1.52M | $ -3.95M | $ -3.35M | $ -1.39M | $ -1.17M | |
| $ -35.12K | $ 26.82K | $ 28.43K | $ -18.49K | $ -4.86K | |
| $ -1.55M | $ -3.92M | $ -3.33M | $ -1.41M | $ -1.17M | |
| $ -1.55M | $ -3.92M | $ -3.33M | $ -1.41M | $ -1.17M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.02 | $ -0.06 | $ -0.05 | $ -0.02 | $ -0.02 |
| Diluted EPS | $ -0.02 | $ -0.06 | $ -0.05 | $ -0.02 | $ -0.02 |
| Weighted Average Shares Outstanding | 65.60M | 63.38M | 62.47M | 62.16M | 61.32M |
| Weighted Average Shares Outstanding (Diluted) | 65.60M | 63.38M | 62.47M | 62.16M | 61.32M |
Currency in CAD
